Aptose Biosciences's market cap is currently $11.67M. The company's EPS TTM is $-3.046; its P/E ratio is ―; Aptose Biosciences is scheduled to report earnings on March 25, 2025, and the estimated EPS forecast is $-0.35. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Operating Income	$ -52.36M	$ -42.59M	$ -65.45M	$ -55.78M	$ -26.86M
EBITDA	$ -52.27M	$ -42.06M	$ -64.82M	$ -55.16M	$ -26.25M
Net Income	$ -51.21M	$ -41.05M	$ -65.26M	$ -54.71M	$ -25.70M
Balance Sheet
Cash & Short-Term Investments	$ 9.25M	$ 46.96M	$ 79.13M	$ 122.39M	$ 97.60M
Total Assets	$ 12.99M	$ 51.03M	$ 82.53M	$ 126.26M	$ 100.48M
Total Debt	$ 1.01M	$ 1.30M	$ 574.00K	$ 1.07M	$ 1.53M
Net Debt	$ -8.24M	$ -35.67M	$ -38.54M	$ -116.32M	$ -78.31M
Total Liabilities	$ 15.89M	$ 13.29M	$ 8.29M	$ 7.35M	$ 6.55M
Stockholders' Equity	$ -2.90M	$ 37.74M	$ 74.24M	$ 118.92M	$ 93.93M
Cash Flow
Free Cash Flow	$ -44.62M	$ -32.35M	$ -43.52M	$ -33.97M	$ -21.66M
Operating Cash Flow	$ -44.59M	$ -32.32M	$ -43.30M	$ -33.89M	$ -21.56M
Investing Cash Flow	$ 9.96M	$ 30.07M	$ -35.21M	$ 12.63M	$ -17.37M
Financing Cash Flow	$ 6.91M	$ 116.00K	$ 226.00K	$ 58.81M	$ 103.45M

Currency in USD

Aptose Biosciences Earnings and Revenue History

Income Statement >

Aptose Biosciences Debt to Assets

Balance Sheet >

Aptose Biosciences Cash Flow

Cash Flow >

Aptose Biosciences Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing